Country websites:


The medical device and therapy related information on this website is aimed exclusively at healthcare professionals located within the European Union.

Not all products are cleared or available for sale in all EU countries. Please check the relevant country web site for details.

By clicking on the button “Accepted and Confirmed” you assure that you have taken note of this information and that you are a healthcare professional located within the European Union.


Minimizing your patients’ risks for cardiovascular morbidity and mortality

Despite significant improvements in the quality and efficacy of hemodialysis therapy in recent years, cardiovascular disease (CVD) remains the leading cause of death for dialysis patients. Today, almost every other dialysis patient dies from cardiovascular complications. Fresenius Medical Care supports nephrologists worldwide in minimizing their patients’ risks for cardiovascular morbidity and mortality.

HighVolumeHDF therapy as well as innovative membranes like Helixoneplus and modern monitoring features like the Blood Volume Monitor, together with ultrapure dialysis fluid, help minimize CVD risk factors and significantly improve the quality and efficacy of hemodialysis therapy.

Fresenius Medical Care strives continuously to develop and implement innovative therapies and products to improve the cardiovascular prognosis of dialysis patients.

Hemodialysis machine close up - Fresenius Medical Care

HighVolumeHDF by Fresenius Medical Care is an advanced dialysis treatment that offers many advantages for patients, physicians and nurses.


Fresenius Medical Care hemodialysis machines and devices.

In this section: